Zomedica Corporation is a veterinary health company focused on addressing the unaddressed needs of clinical veterinarians. The company is dedicated to developing products for companion animals. They have created the TRUFORMA platform, which offers in-clinic diagnostic products for cats and dogs. Additionally, the company has developed PulseVet, a treatment solution for musculoskeletal issues in horses and small animals.
Zomedica has partnerships with Celsee, Inc. to develop liquid biopsy assays for detecting cancer in companion animals, and Seraph Biosciences, Inc. for creating a novel pathogen detection system. The company was originally named Zomedica Pharmaceuticals Corp. and changed its name in October 2020. Zomedica was established in 2015 and has its HQ in Ann Arbor, Michigan.
Contents
How do we estimate ZOM stock will do in 2023?
ZOM has been on a downtrend since 2021, with a high of $2.9 and a low of $0.16. This is a 94% crash in the span of 2 years. Although, things are not looking too bad because ZOM has a good potential to increase in price in the future.
We estimate that ZOM will be trading at $0.5 by 2023, which is a 212% increase in price from its current price of $0.16. This could easily be invalidated with price going below $0.065 which was the All Time Low from 2020. ZOM may be on its way to a reversal if price bounces from its current price.
How do we estimate ZOM stock will do in 2024?
We estimate that ZOM will be trading around $0.7 in 2024, which is over a 300% increase from today’s price. This estimate is based mainly on historical data, technical analysis, and the possibility that price goes up in 2023. We are all aware that no one can predict the future, and the stock market is very unpredictable.
On the weekly time frame, ZOM looks somewhat ready for a bullish rally but without any solid bases, this rally will likely be short lived and with the absence of a significant high.
Individuals looking to invest in ZOM should conduct their own research while factoring in the estimated duration of their investment.
How do we estimate ZOM will do in 2025?
We estimate that ZOM will decline by over 30% from its current price in 2024. This estimate is on the assumption that ZOM will be bullish in 2024. ZOM has had two bullish runs and two bearish runs over the course of the past six years, so it is logical to expect somewhat of a bullish run in the coming years. There are also external factors that could also influence the price in a very unexpected way; such factors include government policies, economic conditions, the global crisis, and lots more.
We are estimating that ZOM will be worth around $0.2 in 2025 after its run in 2024. Although there is a possibility that ZOM trends below $0.1 in 2025, this will happen if there is no upward price movement in 2023 and 2024.
How do we estimate ZOM will do in 2030?
There is no historical data that can help speculate that far into the future. The stock price of Zomedica (ZOM) in 2030 will be influenced by several key factors. One of the most significant factors is the company’s financial performance, including its revenue growth, profitability, and overall financial health. Investors will be looking for signs that ZOM is growing and performing well financially, which could drive up its stock price.
Another important factor is the demand for ZOM’s products and services, as well as the overall demand for veterinary health products. If there is strong demand for ZOM’s offerings and the industry as a whole is growing, its stock price is likely to benefit. On the other hand, if demand is weak, its stock price could suffer.
The level of competition in the veterinary health industry will also play a role in ZOM’s stock price. If ZOM is well positioned relative to its competitors and has a strong market share, its stock price is likely to be more stable. If, however, the company is facing strong competition, its stock price could be more volatile.
FAQ
Changes in regulations and laws that impact the veterinary health industry, such as changes to the Food and Drug Administration (FDA) regulations, could also influence ZOM’s stock price. Favorable changes in the regulatory environment could benefit its stock price, while unfavorable changes could have a negative impact.
A strong economy and low-interest rates generally bode well for stock prices, while a weak economy and high-interest rates can have a negative impact. Any major economic disruptions, such as recessions or inflation, could also impact ZOM’s stock price.
The level of competition in the veterinary health industry will also play a role in ZOM’s stock price. If the company is well positioned relative to its competitors and has a strong market share, its stock price is likely to be more stable.